Navamedic has signed an agreement with its partner InfoRLife SA which will expand Navamedic's portfolio of antibiotics for hospital use. Under the agreement, Navamedic acquires the rights and Marketing Authorizations for the unique Clindamycin ready-to-administer bags developed and manufactured by InfoRLife AS. Navamedic already markets Clindamycin in traditional ampoules as part of the large portfolio of antibiotics acquired from ACS Dobfar in 2020. The innovative ready-to-use product wi

Odyssey Health, Inc. f/k/a Odyssey Group International, Inc., a company focused on developing unique, life-enhancing medical products, today presents a Company update and recap of its concussion drug development program. Concussions represent an ‘unmet’ medical need and affect tens of millions worldwide. Odyssey acquired the intellectual property and all rights to the concussion drug in March 2021. Since the acquisition, Odyssey has added key industry experts to its mana

Recently, Rokid, an augmented reality glasses manufacturer,  partnered with Eyedaptic to unveil the all-new EYE5 smart glasses at the American Academy of Optometry 2022 Annual Meeting and Expo. The latest model brings wearability to a whole new level and covers the widest range of use cases for central vision loss including Diabetic Retinopathy and Age-Related Macular Degeneration. Equipped with simulated natural vision software, the Eyedaptic EYE5 solution optimizes the user&#

Caverion has signed an agreement with Peab for the design and implementation of heating, cooling, ventilation and medical gas solutions at Hudiksvall's hospital in east central Sweden. The agreement also includes the construction of a new technical building to supply the hospital with electricity, medical gases, heating and cooling. Caverion has broad experience in the healthcare sector and in meeting the high demands of hospital operations. Within this project,

New scientific evidence demonstrating the value of simulation-based training for cataract surgery has been showcased in a series of articles published in the peer-reviewed Indian Journal of Ophthalmology, as led by medical officers of HelpMeSee and their partners around the world. Fueled by the innovation of virtual reality, HelpMeSee is a global nonprofit that uses instructor-led simulation-based training to help eradicate cataract blindness. "The new articles released by the

Alcon  the global leader in eye care dedicated to helping people see brilliantly, today announced that it has completed its acquisition of Aerie Pharmaceuticals, Inc.This transaction helps bolster Alcon’s presence in the ophthalmic pharmaceutical space with its growing portfolio of commercial products and development pipeline.“As we welcome the Aerie team to Alcon, we look forward to leveraging our expanding commercial footprint and expertise to bring Rocklatan® and Rhopr

H Robotics has announced a partnership with CareSpace to build an all new tele-rehab program for patients with neurological and musculoskeletal conditions. The program will be designed for use with rebless™, the H Robotics FDA-registered robotic rehabilitation device for both upper and lower extremities, providing motion to the elbow, wrist, ankle, and knee. With the new tele-rehab program, patients will use rebless to conduct unified home rehabilitation sessions via the CareS

Positive liver cancer detection data published in Cancer Discovery1 demonstrates the promise of Delfi Diagnostics' high-performance, accessible liquid biopsy platform in a new tumor type. Delfi had previously announced that it is developing a low-cost, highly sensitive blood test for lung cancer screening. The new findings, which will also be presented in Austin, Texas at AACR's Special Conference on Precision Prevention, Early Detection and Interception of Cancer, show how Delfi'

The Native Antigen Company one of the world’s leading suppliers of reagents that enables research into vaccines and diagnostics for emerging and endemic infectious diseases, today announced the commercial launch of its latest range of influenza antigens for the southern hemisphere’s 2023 flu season. The latest influenza antigens will help support development of vaccines and diagnostics as part of the ongoing vaccine reformulation programme, helping to ensure public safety througho

Advanced Energy a global leader in precision power conversion, measurement and control solutions, today introduced the Excelsys FC1500 -- The industry's first capacitor charger and multi-output power supply. FC1500 can provide constant charging power, making medical laser and pulsed light therapy equipment no longer need multiple sets of power supplies. Traditional laser and pulsed light systems rely on capacitors that are charged at high voltage and then discharged to generate